Pharmacists in Brookville, PA Accepting Medicare

10 Pharmacists found. Showing 1 - 10

Kortney Marie Wiant Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 240 W Main St, Brookville, PA 15825 Phone: 814-849-5217

Amanda Herbstritt Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 40 White St, Brookville, PA 15825 Phone: 814-849-7548

Erika Nicholson Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 155 Main St, Brookville, PA 15825 Phone: 814-849-7504

Terrence M Nicholson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 240 W Main St, Brookville, PA 15825 Phone: 814-849-5218    Fax: 814-849-4373

Paula K Oldham, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 240 W Main St, Brookville, PA 15825 Phone: 814-849-5217    Fax: 814-849-4373

Emily Renee Reinard Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 40 White St, Brookville, PA 15825 Phone: 814-849-7548

Reed Terwilliger Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 40 White St, Brookville, PA 15825 Phone: 814-849-7548

Melissa D Curtis, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 40 S White St, Brookville, PA 15825 Phone: 814-849-5798    Fax: 814-849-9650

David Michael Smith, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 155 Main St, C/o Means-lauf Super Drug, Brookville, PA 15825 Phone: 814-849-7504    Fax: 814-849-6332

Mrs. Janet Lee Mccrommon Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 40 S White St, Brookville, PA 15825 Phone: 814-849-7548    Fax: 814-849-9650

News Archive

Gene "CGI-58" linked to rare disease activates fat breakdown

A gene earlier linked to a rare disease plays a critical role in the body's "finely tuned balance" of fat storage and break down, new evidence reported in the May Cell Metabolism reveals.

Glissandra Skincare launches three signature anti-aging products

Glissandra™ Skincare Inc. announced the global launch of its three signature anti-aging products concurrent with the Israel Cancer Research Fund's "Women of Action" awards luncheon honoring Beverly Cohen, Lisi Harrison, and Vivien Zighelboim, Ph.D, at the Four Seasons Hotel, Los Angeles at Beverly Hills.

LMU researchers identify a factor that promotes metastasis of colon tumors

Tumors become highly malignant when they acquire the ability to colonize other tissues and form metastases. Researchers at Ludwig-Maximilians-Universitaet in Munich have identified a factor that promotes metastasis of colon tumors - and presents a possible target for therapy.

MMRC initiates Phase Ib/II study of Treanda in combination with Revlimid and dexamethasone

The Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a Phase Ib/II study of bendamustine (Treanda®), an anticancer agent currently approved for the treatment of chronic lymphocytic leukemia (CLL) and B-cell non-Hodgkin's lymphoma (NHL), in combination with lenalidomide (Revlimid®) and dexamethasone in patients with relapsed multiple myeloma. The trial, led by Shaji Kumar, MD, of Mayo Clinic, is open for enrollment at Mayo Clinic (Rochester, Minn.), City of Hope Cancer Center (Duarte, Calif.) and the University of Chicago (Chicago, Ill).

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.

Read more Medical News

› Verified 2 days ago